GlassScriptPhysician profile
Jennifer DO Kim
NPI 1255734778
$1,285.57
in general payments reported to CMS, 2019-2025
17 companies · $48.15 in 2025
The $48.15 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.29 · 2020: $94.66 · 2021: $285 · 2022: $226 · 2023: $271 · 2024: $273 · 2025: $48.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.61 | 2021-2024 | |
| Pfizer INC. | $170.10 | 2019-2024 | |
| Glaxosmithkline, LLC. | $166.67 | 2019-2022 | |
| Novo Nordisk INC | $147.45 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Sumitomo Pharma America, INC. | $96.58 | 2023-2024 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $86.53 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $68.24 | 2021-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.55 | 2022-2024 | Xifaxan |
| Lilly USA, LLC | $39.63 | 2021-2024 | Mounjaro, Jardiance |
| Abbott Laboratories | $39.20 | 2024-2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $38.35 | 2024 | Auvelity |
| Exact Sciences Corporation | $27.35 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $26.89 | 2021-2022 | |
| Allergan, INC. | $24.92 | 2019-2020 | |
| Dexcom, INC. | $16.64 | 2023 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $16.24 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.